NDC 0641-6063-01 - Midazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6063
- Requested NDC
- 0641-6063-01
- Package NDCs from labels
- 0641-6063-01, 0641-6063-10, 0641-6063-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Midazolam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6063-01 | Midazolam | 2 mL in 1 VIAL | INJECTION | 2 | 8 | |
| 0641-6063-10 | Midazolam | 10 in 1 CARTON | INJECTION | 10 | 8 | |
| 0641-6063-25 | Midazolam | 25 in 1 CARTON | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6063-01 | ML - Milliliter | 0641-6063 | ec891c24-bf63-4c25-a55d-ffa3f3d8ec72 | 1 | 2012-07-24 |
| 0641-6063-10 | ML - Milliliter | 0641-6063 | 3864dc11-ac70-4138-b09c-ff4418f7f72a | 1 | 2012-07-24 |
| 0641-6063-25 | ML - Milliliter | 0641-6063 | 9fc17770-9feb-45ba-a96d-9313c53a0adc | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MIDAZOLAM HYDROCHLORIDE | ACTIVE INGREDIENT | W7TTW573JJ | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| MIDAZOLAM | ACTIVE MOIETY | R60L0SM5BC | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | MIDAZOLAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | affecd4d-1f78-4bbe-5a8d-86849bbdc520 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 311700 311702 W7TTW573JJ |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Midazolam Hydrochloride | MIDAZOLAM HYDROCHLORIDE | A-S Medication Solutions | b7effb82-e180-46f0-b2e8-a0d8ebc32a2a | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 311700 W7TTW573JJ |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | f94a10bd-1c40-42c7-b458-b58070614549 | 2026-04-10 | Warnings | 451W47IQ8X |
| Quantum Resonance | ALCOHOLUS, ALUMINA SILICATA, ANACARDIUM ORIENTALE, AQUA MARINA, BAPTISIA TINCTORIA, CANDIDA ALBICANS, COLLAGEN, DNA, LAVANDULA OFFICINALIS, MEDULLA OSSIS SUIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NUX MOSCHATA, PHOSPHORUS, QUARTZ, SILICEA, TELA ARANEA, VALERIANA OFFICINALIS, VISCUM ALBUM | Deseret Biologicals, Inc. | 1467111a-bef6-473d-b7f2-3309a9bb72ce | 2026-04-10 | Warnings | 451W47IQ8X |
| H-Focus Formula | AGNUS CASTUS, AVENA SATIVA, BARYTA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM CARBONICUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, SILICEA, ZINCUM METALLICUM | Healing Natural Oils LLC | 4ee42911-3064-7f55-e063-6294a90abcc7 | 2026-04-07 | Warnings | 451W47IQ8X |
| H-Mood Formula | AGRIMONIA EUPATORIA, FLOS, ANACARDIUM ORIENTALE, AURUM METALLICUM, AVENA SATIVA, BORAGO OFFICINALIS, CAPSICUM ANNUUM, CARPINUS BETULUS, FLOS, CIMICIFUGA RACEMOSA, CINCHONA OFFICINALIS, HYPERICUM PERFORATUM, KALI BROMATUM, LARIX DECIDUA, FLOS, NATRUM CARBONICUM, NATRUM MURIATICUM, NATRUM SULPHURICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA, SILICEA, SINAPSIS ARVENSIS, FLOS, TABACUM | Healing Natural Oils LLC | 4ee5c82e-9edf-c36e-e063-6394a90a237f | 2026-04-07 | Warnings | 451W47IQ8X |
| Walgreens Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Walgreen Company | bda3b9db-5fc4-408c-a5ae-d1eeb3ee308d | 2026-04-06 | Warnings | 451W47IQ8X |
| Sodium Chloride Ophthalmic 5 Percent Hypertonicity Eye | SODIUM CHLORIDE | Hanlim | 4ee80e16-1bb1-8238-e063-6294a90aa719 | 2026-04-04 | Warnings | 451W47IQ8X |
| KIDS TOOTHPASTE, FOR CAVITY PROTECTION | KIDS TOOTHPASTE FOR CAVITY PROTECTION | Shulisa (Foshan) Daily ChemicalIndustry Co., Ltd | 4e8fab9e-f05c-5e2f-e063-6294a90aecf9 | 2026-04-03 | Warnings | 059QF0KO0R |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | 376093e7-e09e-4a57-3199-195e45251866 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.